Loading...

UCB SA

UCBJY•PNK
Healthcare
Biotechnology
$116.70
$0.76(0.66%)

UCB SA (UCBJY) Stock Overview

Explore UCB SA’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap44.4B
P/E Ratio36.07
EPS (TTM)$4.00
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Week$92.51
1 Month$100.00
3 Months$71.17
1 Year Target$150.58

UCBJY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of UCB SA (UCBJY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 76.07, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $150.58.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 36.07 and a market capitalization of 44.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.73%
5-Day Change
-9.57%
1-Month Change
-16.75%
3-Month Change
-23.91%
6-Month Change
-17.16%
Year-to-Date (YTD) Change
-22.24%
1-Year Change
22.63%
3-Year Change
24.00%
5-Year Change
74.90%
All-Time (Max) Change
406.40%

Contact Information

https://www.ucb.com
32 2 559 99 99
Allée de la Recherche, 60, Brussels, 1070

Company Facts

9,052 Employees
IPO DateAug 3, 2012
CountryBE
Actively Trading

Frequently Asked Questions

;